Funding Priorities for Biotechnology Startups
An early biotechnology company rarely has enough capital to advance every promising experiment, platform feature, indication, and partnership at once. The central task is therefore not to divide a budget evenly. It is to decide which work will produce the evidence needed for the next consequential decision. Capital should be assigned to decisions and milestones,…
